NCT06186401 Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells Status RECRUITING Phase PHASE1
NCT06183983 Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma Status RECRUITING Phase NA
NCT06161519 PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications Status RECRUITING Phase PHASE1/PHASE2
NCT06146738 The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203) Status RECRUITING Phase N/A
NCT06146725 The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) Status RECRUITING Phase N/A
NCT06140875 Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF) Status RECRUITING Phase NA
NCT06132438 Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma Status NOT_YET_RECRUITING Phase PHASE1
NCT06118723 The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) Status RECRUITING Phase N/A
NCT06113705 Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study. Status RECRUITING Phase NA
NCT06108206 Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06105619 A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN). Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06102525 A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT06090903 Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma Status RECRUITING Phase NA
NCT06072586 A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions Status RECRUITING Phase EARLY_PHASE1
NCT06061809 N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma Status RECRUITING Phase PHASE2
NCT06058988 Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer Status RECRUITING Phase PHASE2
NCT06041555 MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy) Status RECRUITING Phase N/A